Denali Therapeutics
DNLI
DNLI
223 hedge funds and large institutions have $2.61B invested in Denali Therapeutics in 2024 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 86 increasing their positions, 59 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 216 → 223 (+7)
0.63% more ownership
Funds ownership: 88.26% → 88.89% (+0.63%)
29% less capital invested
Capital invested by funds: $3.68B → $2.61B (-$1.07B)
Holders
223
Holding in Top 10
2
Calls
$1.35M
Puts
$750K
Top Buyers
| 1 | +$17.2M | |
| 2 | +$14.5M | |
| 3 | +$10.4M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$7.56M |
| 5 |
Millennium Management
New York
|
+$7.01M |
Top Sellers
| 1 | -$49.6M | |
| 2 | -$21M | |
| 3 | -$17.9M | |
| 4 |
Morgan Stanley
New York
|
-$10.5M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$7.34M |